Novavax, Inc. (NASDAQ:NVAX) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Novavax' Second Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in a listen-only mode.
Novavax Inc (NVAX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Shah Capital Management Himanshu H. Shah | 9,662,090 | $122,322,059 | +20% | 26.45% |
| 2. | D E Shaw D. E. Shaw | 6,322,075 | $80,037,470 | +5429% | 0.07% |
| 3. | 56,277,000 | $70,088,316 | +137% | 1.52% | |
| 4. | 34,750,000 | $43,157,490 | +3% | 1.23% | |
| 5. | Coatue Management Philippe Laffont | 2,624,915 | $33,231,424 | +73% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 1,000 | Officer | 14,473 | 2023-03-10 | Filing | |
| $7.04 | 2,000 | Officer | 13,473 | 2023-03-07 | Filing | |
| $7.48 | 3,000 | Officer | 11,473 | 2023-03-06 | Filing | |
| $139.64 | 700 | Director | 2,800 | 2021-05-19 | Filing | |
| $48.83 | 1,500 | Director | 1,500 | 2020-06-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.09 | 7,500 | 61,760 | 2024-06-21 | Filing | ||
| $14.28 | 1,107 | 69,260 | 2024-06-18 | Filing | ||
| $13.62 | 6,393 | 70,367 | 2024-06-18 | Filing | ||
| $14.54 | 1,404 | 66,613 | 2024-06-17 | Filing | ||
| $14.46 | 12,500 | 68,017 | 2024-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,775,875 | $80,524,200 | 0% | |
| 2. | 14,560,061 | $69,888,293 | 0% | |
| 3. | 8,436,179 | $40,493,660 | 0% | |
| 4. | 7,241,455 | $34,758,985 | 0% | |
| 5. | 2,297,507 | $11,029,665 | 0% |
News See All
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
Jim Cramer in a latest program discussed the changing consumer trends in the US, wondering whether the consumer is just “fed up” of paying high prices and becoming “frugal.” Cramer said this “...
10 Stocks to Buy and Sell Before the Third Quarter 2024 According to Jim Cramer
Jim Cramer in a latest program discussed the changing consumer trends in the US, wondering whether the consumer is just "fed up" of paying high prices and becoming "frugal." Cramer said this "frugal thesis...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Novavax' First Quarter 2024 Financial Results and Operational Highlights Conference Call. All lines will be in a listen-only mode. [Operator Instructions].
12 Most Shorted Stocks in 2024
Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that is required...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.44 EPS, expectations were $-0.49.
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.44 EPS, expectations were $-0.49. Novavax, Inc.
Novavax, Inc. (NASDAQ:NVAX) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Third Quarter 2023 Financial Results and Operational Highlights Conference Call.
5 Most Shorted Stocks Right Now
Biomea Fusion, Inc. (NASDAQ:BMEA) is a biotechnology firm seeking to treat cancer and diabetes.
Novavax, Inc. (NASDAQ:NVAX) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to the Novavax Second Quarter 2023 Financial Results and Operational Highlights Conference Call.